Shengming Dai
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
- RNA modifications and cancer
Papers in
-
- RNA modifications and cancer 6
- Circular RNAs in diseases 5
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 6
- Cancer, Lipids, and Metabolism 4
- Co-authors
- Xiaomou Wei (5 shared papers)Haixin Huang (2 shared papers)Dong Wei (3 shared papers)Zhen Wu (2 shared papers)Xiangyang Zhou (2 shared papers)Guisheng Li (1 shared paper)Meiyu Dai (12 shared papers)Zheng Peng (8 shared papers)
- Journals
- Oncotarget (5 papers)PLoS ONE (4 papers)Molecular Therapy (1 paper)Journal of Cellular Biochemistry (1 paper)BMJ Open (1 paper)
- Partner nations
- ChinaUnited StatesPoland
In The Last Decade
Shengming Dai
34 papers receiving 1.5k citations
Shengming Dai's Hit Papers
Peers
Comparison fields: 5 of 93
- Cancer Research 838
- Molecular Biology 1.1k
- Reproductive Medicine 112
- Immunology 233
- Hepatology 41
Countries citing papers authored by Shengming Dai
This map shows the geographic impact of Shengming Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengming Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengming Dai more than expected).
Fields of papers citing papers by Shengming Dai
This network shows the impact of papers produced by Shengming Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengming Dai. The network helps show where Shengming Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Shengming Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined With GM-CSF for Colorectal Cancer Hit paper breakdown → | 2008 | 670 |
| 2 | 2016 | 94 | |
| 3 | 2016 | 81 | |
| 4 | 2017 | 66 | |
| 5 | 2017 | 61 | |
| 6 | 2016 | 60 | |
| 7 | 2016 | 55 | |
| 8 | 2015 | 47 | |
| 9 | 2016 | 39 | |
| 10 | 2017 | 34 | |
| 11 | 2016 | 33 | |
| 12 | 2009 | 30 | |
| 13 | 2019 | 22 | |
| 14 | 2020 | 18 | |
| 15 | 2018 | 18 | |
| 16 | 2017 | 18 | |
| 17 | 2017 | 16 | |
| 18 | 2009 | 16 | |
| 19 | 2016 | 15 | |
| 20 | 2018 | 13 |
About Shengming Dai
Shengming Dai is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Epidemiology, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers), Circular RNAs in diseases (5 papers), Cancer, Lipids, and Metabolism (4 papers), Immune Cell Function and Interaction (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Lymphatic System and Diseases (2 papers). The work is most often cited by research in Cancer Research (838 citations), Molecular Biology (1.1k citations), Reproductive Medicine (112 citations), Immunology (233 citations) and Hepatology (41 citations). Shengming Dai has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Xiaomou Wei, Haixin Huang, Dong Wei, Zhen Wu, Xiangyang Zhou, Guisheng Li, Meiyu Dai, Zheng Peng, Xuexiang Liu and Yifan Sun. Their work appears in journals such as Oncotarget, PLoS ONE, Molecular Therapy, Journal of Cellular Biochemistry and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.